Literature DB >> 20380816

Chronic constriction injury reduces cannabinoid receptor 1 activity in the rostral anterior cingulate cortex of mice.

Michelle R Hoot1, Laura J Sim-Selley, Justin L Poklis, Rehab A Abdullah, Krista L Scoggins, Dana E Selley, William L Dewey.   

Abstract

The present studies examined the effect of chronic neuropathic pain on cannabinoid receptor density and receptor-mediated G-protein activity within supraspinal brain areas involved in pain processing and modulation in mice. Chronic constriction injury (CCI) produced a significant decrease in WIN 55,212-2-stimulated [(35)S]GTPgammaS binding in membranes prepared from the rostral anterior cingulate cortex (rACC) of CCI mice when compared to sham-operated controls. Saturation binding with [(3)H]SR 141716A in membranes of the rACC showed no significant differences in binding between CCI and sham mice. Analysis of levels of the endocannabinoids anandamide (AEA) or 2-arachidonoylglycerol (2-AG) in the rACC following CCI showed no significant differences between CCI and sham mice. These data suggest that CCI produced desensitization of the cannabinoid 1 receptor in the rACC in the absence of an overall decrease in cannabinoid 1 receptor density or change in levels of AEA or 2-AG. These data are the first to show alterations in cannabinoid receptor function in the rostral anterior cingulate cortex in response to a model of neuropathic pain. Copyright 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20380816      PMCID: PMC3736380          DOI: 10.1016/j.brainres.2010.03.105

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  49 in total

1.  Cannabinoid CB(1) receptor expression in rat spinal cord.

Authors:  W P Farquhar-Smith; M Egertová; E J Bradbury; S B McMahon; A S Rice; M R Elphick
Journal:  Mol Cell Neurosci       Date:  2000-06       Impact factor: 4.314

2.  Cannabinoid CB(1) receptor upregulation in a rat model of chronic neuropathic pain.

Authors:  A Siegling; H A Hofmann; D Denzer; F Mauler; J De Vry
Journal:  Eur J Pharmacol       Date:  2001-03-09       Impact factor: 4.432

3.  Evoked responses of the anterior cingulate cortex to stimulation of the medial thalamus.

Authors:  M M Hsu; J C Kung; B C Shyu
Journal:  Chin J Physiol       Date:  2000-06-30       Impact factor: 1.764

4.  Stimulation of cannabinoid receptor agonist 2-arachidonylglycerol by chronic ethanol and its modulation by specific neuromodulators in cerebellar granule neurons.

Authors:  B S Basavarajappa; M Saito; T B Cooper; B L Hungund
Journal:  Biochim Biophys Acta       Date:  2000-12-15

5.  Receptor-dependent formation of endogenous cannabinoids in cortical neurons.

Authors:  N Stella; D Piomelli
Journal:  Eur J Pharmacol       Date:  2001-08-17       Impact factor: 4.432

6.  An endogenous cannabinoid (2-AG) is neuroprotective after brain injury.

Authors:  D Panikashvili; C Simeonidou; S Ben-Shabat; L Hanus; A Breuer; R Mechoulam; E Shohami
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

7.  NMDA NR2A and NR2B receptors in the rostral anterior cingulate cortex contribute to pain-related aversion in male rats.

Authors:  Ting-Ting Li; Wen-Hua Ren; Xiao Xiao; Jia Nan; Long-Zhen Cheng; Xue-Han Zhang; Zhi-Qi Zhao; Yu-Qiu Zhang
Journal:  Pain       Date:  2009-08-19       Impact factor: 6.961

Review 8.  Cannabinoid receptors and their endogenous ligands.

Authors:  Takayuki Sugiura; Keizo Waku
Journal:  J Biochem       Date:  2002-07       Impact factor: 3.387

Review 9.  Cannabinoid receptors and their ligands.

Authors:  R G Pertwee; R A Ross
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

Review 10.  Biosynthesis and degradation of anandamide and 2-arachidonoylglycerol and their possible physiological significance.

Authors:  T Sugiura; Y Kobayashi; S Oka; K Waku
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2002 Feb-Mar       Impact factor: 4.006

View more
  6 in total

1.  Chronic neuropathic pain in mice reduces μ-opioid receptor-mediated G-protein activity in the thalamus.

Authors:  Michelle R Hoot; Laura J Sim-Selley; Dana E Selley; Krista L Scoggins; William L Dewey
Journal:  Brain Res       Date:  2011-06-16       Impact factor: 3.252

2.  Characterization of CM-398, a Novel Selective Sigma-2 Receptor Ligand, as a Potential Therapeutic for Neuropathic Pain.

Authors:  Lisa L Wilson; Amy R Alleyne; Shainnel O Eans; Thomas J Cirino; Heather M Stacy; Marco Mottinelli; Sebastiano Intagliata; Christopher R McCurdy; Jay P McLaughlin
Journal:  Molecules       Date:  2022-06-04       Impact factor: 4.927

3.  Cannabis analgesia in chronic neuropathic pain is associated with altered brain connectivity.

Authors:  Libat Weizman; Lior Dayan; Silviu Brill; Hadas Nahman-Averbuch; Talma Hendler; Giris Jacob; Haggai Sharon
Journal:  Neurology       Date:  2018-09-05       Impact factor: 9.910

4.  Dimerization with cannabinoid receptors allosterically modulates delta opioid receptor activity during neuropathic pain.

Authors:  Ittai Bushlin; Achla Gupta; Steven D Stockton; Lydia K Miller; Lakshmi A Devi
Journal:  PLoS One       Date:  2012-12-14       Impact factor: 3.240

5.  Increased expression of cannabinoid CB₁ receptors in Achilles tendinosis.

Authors:  Emmelie Björklund; Sture Forsgren; Håkan Alfredson; Christopher J Fowler
Journal:  PLoS One       Date:  2011-09-08       Impact factor: 3.240

6.  Examination of the Novel Sigma-1 Receptor Antagonist, SI 1/28, for Antinociceptive and Anti-allodynic Efficacy against Multiple Types of Nociception with Fewer Liabilities of Use.

Authors:  Lisa L Wilson; Shainnel O Eans; Insitar Ramadan-Siraj; Maria N Modica; Giuseppe Romeo; Sebastiano Intagliata; Jay P McLaughlin
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.